Technical Analysis for DMTK - DermTech, Inc.

Grade Last Price % Change Price Change
F 31.28 -2.07% -0.66
DMTK closed down 2.07 percent on Friday, October 15, 2021, on 87 percent of normal volume.
Earnings due: Nov 8
*** please verify all earnings dates ***

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down
Historical DMTK trend table...

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
20 DMA Resistance Bearish -2.07%
NR7 Range Contraction -0.76%
NR7-2 Range Contraction -0.76%
Spinning Top Other -1.45%
NR7 Range Contraction -1.45%
20 DMA Resistance Bearish -2.98%
180 Bearish Setup Bearish Swing Setup -2.98%
20 DMA Resistance Bearish -7.37%
Oversold Stochastic Weakness -0.54%
Older End-of-Day Signals for DMTK ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Down 2 % 3 days ago
Fell Below Previous Day's Low 3 days ago
Down 1% 3 days ago
Fell Below 10 DMA 3 days ago
10 DMA Support 3 days ago
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

DermTech, Inc. Description

DermTech, Inc., a molecular diagnostic company, develops and markets novel non-invasive diagnostic tests to diagnosis skin cancer and related conditions in the United States. The company offers Pigmented Lesion Assay (PLA), a gene expression test that helps rule out melanoma and the need for a surgical biopsy of atypical pigmented lesions. It also provides Nevome test, an adjunctive reflex test for the PLA; and adhesive skin sample collection kits, as well as gene expression assays for the Th1, Th2, IFN-gamma, and Th17 inflammatory pathways. The company is also developing non-melanoma skin cancer diagnostic and non-melanoma skin cancer risk assessment products. The company sells its products primarily to pathology and oncology practitioners. DermTech, Inc. is headquartered in La Jolla, California.


Classification

Sector: Industrials
Industry: Conglomerates
Keywords: Medicine Cancer Melanoma Gene Expression Dermatology Diagnostic Tests Risk Assessment Pathology Biopsy Assessment Products Skin Cancer Cutaneous Conditions Melanoma Skin Cancer Pigmented Lesion

Is DMTK a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 84.49
52 Week Low 11.25
Average Volume 374,191
200-Day Moving Average 42.04
50-Day Moving Average 34.48
20-Day Moving Average 32.78
10-Day Moving Average 31.79
Average True Range 1.88
ADX 16.26
+DI 15.19
-DI 18.55
Chandelier Exit (Long, 3 ATRs) 31.11
Chandelier Exit (Short, 3 ATRs) 35.85
Upper Bollinger Bands 35.86
Lower Bollinger Band 29.69
Percent B (%b) 0.26
BandWidth 18.81
MACD Line -0.94
MACD Signal Line -0.91
MACD Histogram -0.027
Fundamentals Value
Market Cap 612.94 Million
Num Shares 19.6 Million
EPS -3.08
Price-to-Earnings (P/E) Ratio -10.16
Price-to-Sales 35.67
Price-to-Book 4.76
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 33.92
Resistance 3 (R3) 34.18 33.56 33.48
Resistance 2 (R2) 33.56 32.89 33.43 33.33
Resistance 1 (R1) 32.42 32.47 32.11 32.16 33.19
Pivot Point 31.80 31.80 31.64 31.67 31.80
Support 1 (S1) 30.66 31.13 30.35 30.40 29.37
Support 2 (S2) 30.04 30.71 29.91 29.23
Support 3 (S3) 28.90 30.04 29.08
Support 4 (S4) 28.64